Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  porfimer sodium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 44 for your search:
Start Over
Phase IV Study of Photodynamic Therapy Using Porfimer Sodium in Patients with Partially Obstructive Esophageal Cancer (Summary Last Modified 01/99)
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: QLT-PHO-ECI-01, NCI-V98-1399
Phase III Randomized Study of Photodynamic Therapy Using Porfimer Sodium for the Ablation of High Grade Dysplasia in Barrett's Esophagus
Phase: Phase III
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: QLT-PHO-BAR-01, NCI-V98-1398
High Light and Low Light Dose PDT in Glioma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CWRU4303, P30CA043703, CASE-4303, CWRU-00003937, NCT00118222
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000558540, CRUK-PHOTOSTENT-02, EU-20740, EUDRACT-2005-001173-96, ISRCTN87712758, CTA-20363/0207/001-0001, NCT00513539
S-1 and Photodynamic Therapy in Cholangiocarcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: 2009-0056, NCT00869635
Phase I/II Study of Photodynamic Therapy for Dysplasia or Early Adenocarcinoma Associated with Barrett's Esophagus
Phase: Phase II, Phase I
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: TCSC-9307, NCI-V94-0483
Phase I/II Study of Photodynamic Therapy Using Photosensitization with Photofrin II and Laser Light in Patients with Upper Gastrointestinal Tumors (Summary Last Modified 04/89)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: RPMI-PPC-797, NCI-V87-0200
Phase I/II Study of Photodynamic Therapy with Photofrin II and Laser Light in Patients with Certain Recurrent, Resistant Solid Tumors (Summary Last Modified 04/89)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: RPMI-PPC-878, NCI-V87-0199
Phase I/II Study of Photodynamic Therapy for the Treatment of Nonmelanomatous Skin Cancer (Summary Last Modified 09/91)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: RPMI-DS-8914, NCI-V90-0116
Phase I/II Study of Photodynamic Therapy with Conventional Surgery for Primary Intracranial Glial Tumors plus Postoperative Radiotherapy for De Novo Tumors (Summary Last Modified 06/98)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: LUMC-IND-33410, NCI-V92-0018
Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: WBPDT-577-04, NCT00322699
Photodynamic Therapy in Treating Patients With Early Esophageal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: DS 93-23, RPCI-DS-93-23, NCI-G97-1138, NCT00002935
Pilot and Phase II Study of Photodynamic Therapy (PDT) in Familial Adenomatous Polyposis with Duodenal Adenomas (Summary Last Modified 05/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-DS-95-12, NCI-G97-1168
Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer
Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: DS 94-10, RPCI-DS-94-10, NCI-V97-1196, NCT00002964
Phase II Study of Photodynamic Therapy and Porfimer Sodium (Photofrin) for the Treatment of Partially or Completely Obstructing Esophageal Cancer (Summary Last Modified 12/98)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-DS-96-45, NCI-G97-1246
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 99-015, P30CA008748, MSKCC-99015, NCI-G99-1525, NCT00003923
Start Over